OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 123 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 1.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,514,000 | -62.8% | 717,500 | -12.8% | 0.01% | -60.0% |
| Q2 2015 | $4,075,000 | -11.7% | 823,200 | +39.7% | 0.02% | -16.7% |
| Q1 2015 | $4,613,000 | -25.7% | 589,100 | -42.5% | 0.02% | -18.2% |
| Q4 2014 | $6,208,000 | +7.7% | 1,024,500 | -24.3% | 0.02% | +4.8% |
| Q3 2014 | $5,763,000 | -14.5% | 1,352,900 | +24.0% | 0.02% | -8.7% |
| Q2 2014 | $6,742,000 | +32.0% | 1,090,900 | +38.8% | 0.02% | +27.8% |
| Q1 2014 | $5,109,000 | +9.9% | 786,000 | -4.8% | 0.02% | +5.9% |
| Q4 2013 | $4,650,000 | – | 826,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 1,900,000 | $11,106,000 | 1.50% |
| Redmile Group, LLC | 1,190,440 | $6,958,000 | 1.23% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 613,560 | $3,586,000 | 0.63% |
| Montibus Capital Management LLC | 818,575 | $4,784,570,000 | 0.60% |
| KOPP INVESTMENT ADVISORS LLC | 213,752 | $1,249,000 | 0.49% |
| PFM Health Sciences, LP | 3,646,260 | $21,312,000 | 0.44% |
| APEX CAPITAL, LLC | 1,092,900 | $6,388,000 | 0.44% |
| FIRST MANHATTAN CO. LLC. | 6,141,636 | $46,860,000 | 0.32% |
| JHL Capital Group LLC | 300,000 | $1,755,000 | 0.27% |
| Partner Investment Management, L.P. | 188,732 | $1,103,000 | 0.25% |